Prevalence of osteoporosis and osteopenia in Thai COPD patients

Journal of the Medical Association of Thailand

Volumn 95, Issue 8, 2012, Pages 1021-1027

  Rittayamai, Nuttapol ^a   Chuaychoo, Benjamas ^a   Sriwijitkamol, Apiradee ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Bone mineral density; Chronic obstructive pulmonary disease; Osteoporosis; Prevalence; Systemic inflammation

Indexed keywords

C REACTIVE PROTEIN; FLUTICASONE;

ADULT; AGED; ARTICLE; BODY MASS; BONE DENSITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMUR NECK; FORCED EXPIRATORY VOLUME; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; OSTEOPENIA; OSTEOPOROSIS; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PREVALENCE; THAILAND;

AGED; BODY MASS INDEX; BONE DISEASES, METABOLIC; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; THAILAND;

EID: 84869159393     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Lopez AD, Shibuya K, Rao C, Mathers CD, Hansell AL, Held LS, et al. Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J 2006; 27: 397-412.
2. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease [Internet]. Revised 2011 [cited 2011 Sep15]. Available from: http://www.goldcopd.org
3. Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J 2009; 33: 1165-85.
4. Gan WQ, Man SF, Senthilselvan A, Sin DD. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 2004; 59: 574-80.
5. van Eeden SF, Sin DD. Chronic obstructive pulmonary disease: a chronic systemic inflammatory disease. Respiration 2008; 75: 224-38.
6. Karadag F, Karul AB, Cildag O, Yilmaz M, Ozcan H. Biomarkers of systemic inflammation in stable and exacerbation phases of COPD. Lung 2008; 186: 403-9.
7. World Health Organization. Prevention and management of osteoporosis: report of a WHO scientific group [Internet]. Geneva: WHO; 2003 [cited 2009 Jan 11]. Available from: http://libdoc.who.int/trs/WHO_TRS_921.pdf
8. Jorgensen NR, Schwarz P. Osteoporosis in chronic obstructive pulmonary disease patients. Curr Opin Pulm Med 2008; 14: 122-7.
9. Biskobing DM. COPD and osteoporosis. Chest 2002; 121: 609-20.
10. Jorgensen NR, Schwarz P, Holme I, Henriksen BM, Petersen LJ, Backer V. The prevalence of osteoporosis in patients with chronic obstructive pulmonary disease: a cross sectional study. Respir Med 2007; 101: 177-85.
11. Graat-Verboom L, Spruit MA, van den Borne BE, Smeenk FW, Martens EJ, Lunde R, et al. Correlates of osteoporosis in chronic obstructive pulmonary disease: An underestimated systemic component. Respir Med 2009; 103: 1143-51.
12. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J 2005; 26: 319-38.
13. Dejsomritrutai W, Nana A, Maranetra KN, Chuaychoo B, Maneechotesuwan K, Wongsurakiat P, et al. Reference spirometric values for healthy lifetime nonsmokers in Thailand. J Med Assoc Thai 2000; 83: 457-66.
14. Pongchaiyakul C, Apinyanurag C, Soontrapa S, Soontrapa S, Pongchaiyakul C, Nguyen TV, et al. Prevalence of osteoporosis in Thai men. J Med Assoc Thai 2006; 89: 160-9.
15. Ferguson GT, Calverley PM, Anderson JA, Jenkins CR, Jones PW, Willits LR, et al. Prevalence and progression of osteoporosis in patients with COPD: results from the TOwards a Revolution in COPD Health study. Chest 2009; 136: 1456-65.
16. Vestergaard P, Rejnmark L, Mosekilde L. Osteoporosis is markedly underdiagnosed: a nationwide study from Denmark. Osteoporos Int 2005; 16: 134-41.
17. Limpaphayom KK, Taechakraichana N, Jaisamrarn U, Bunyavejchevin S, Chaikittisilpa S, Poshyachinda M, et al. Prevalence of osteopenia and osteoporosis in Thai women. Menopause 2001; 8: 65-9.
18. Vrieze A, de Greef MH, Wijkstra PJ, Wempe JB. Low bone mineral density in COPD patients related to worse lung function, low weight and decreased fat-free mass. Osteoporos Int 2007; 18: 1197-202.
19. Graat-Verboom L, van den Borne BE, Smeenk FW, Spruit MA, Wouters EF. Osteoporosis in COPD outpatients based on bone mineral density and vertebral fractures. J Bone Miner Res 2011; 26: 561-8.
20. Bolton CE, Ionescu AA, Shiels KM, Pettit RJ, Edwards PH, Stone MD, et al. Associated loss of fat-free mass and bone mineral density in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004; 170: 1286-93.
21. Agusti A. Systemic effects of chronic obstructive pulmonary disease: what we know and what we don't know (but should). Proc Am Thorac Soc 2007; 4: 522-5.
22. Tkac J, Man SF, Sin DD. Systemic consequences of COPD. Ther Adv Respir Dis 2007; 1: 47-59.
23. Sin DD, Lacy P, York E, Man SF. Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004; 170: 760-5.
24. Man SF, Connett JE, Anthonisen NR, Wise RA, Tashkin DP, Sin DD. C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease. Thorax 2006; 61: 849-53.
25. de Torres JP, Pinto-Plata V, Casanova C, Mullerova H, Cordoba-Lanus E, Muros DF, et al. C-reactive protein levels and survival in patients with moderate to very severe COPD. Chest 2008; 133: 1336-43.
26. Dahl M, Vestbo J, Lange P, Bojesen SE, Tybjaerg-Hansen A, Nordestgaard BG. C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007; 175: 250-5.
27. Lehouck A, Boonen S, Decramer M, Janssens W. COPD, bone metabolism, and osteoporosis. Chest 2011; 139: 648-57.
28. Ding C, Parameswaran V, Udayan R, Burgess J, Jones G. Circulating levels of inflammatory markers predict change in bone mineral density and resorption in older adults: a longitudinal study. J Clin Endocrinol Metab 2008; 93: 1952-8.
29. Kjensli A, Mowinckel P, Ryg MS, Falch JA. Low bone mineral density is related to severity of chronic obstructive pulmonary disease. Bone 2007; 40: 493-7.
30. Goldstein MF, Fallon JJ Jr, Harning R. Chronic glucocorticoid therapy-induced osteoporosis in patients with obstructive lung disease. Chest 1999; 116: 1733-49.
31. Johnell O, Pauwels R, Lofdahl CG, Laitinen LA, Postma DS, Pride NB, et al. Bone mineral density in patients with chronic obstructive pulmonary disease treated with budesonide Turbuhaler. Eur Respir J 2002; 19: 1058-63.